Why is Jenburkt Pharma falling/rising?

As of 29-Aug, Jenburkt Pharmaceuticals Ltd. is currently priced at 1,095.00, reflecting an increase of 5.0 (0.46%). The stock has shown a trend reversal by gaining after two consecutive days of decline, and it has outperformed its sector by 0.43% today. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend in the short term. Over the past week, the stock has decreased by 3.10%, and it has seen a significant drop of 16.35% over the past month. Despite these declines, the company exhibits high management efficiency with a return on equity (ROE) of 18.49% and maintains a low debt-to-equity ratio, which could support its stability and potential for recovery.
In the broader market context, Jenburkt Pharmaceuticals has underperformed compared to the Sensex, which has declined by only 1.84% over the past week while the stock fell by 3.10%. This disparity highlights the stock's relative weakness in the current market environment. However, the year-to-date performance shows a decline of 9.85% for Jenburkt Pharmaceuticals, contrasting with a positive return of 2.14% for the Sensex, further emphasizing the stock's challenges. The rising investor participation, indicated by a 57.88% increase in delivery volume, suggests some renewed interest, but overall, the stock's recent performance remains concerning in light of the broader market trends.